GYBYS(SH:600332) Zheng Quan Shi Bao Wang·2025-08-08 06:37Core Viewpoint - A new company named Guangzhou Center for Biomedical Technology Transfer and Transformation has been established with a registered capital of 500 million yuan, focusing on human gene diagnosis and treatment technology development, human stem cell technology development and application, and cell technology research and application [1] Company Summary - The newly established company is fully owned by Guangzhou Pharmaceutical Group Co., Ltd. [1] - The registered capital of the company is 500 million yuan, indicating significant investment in the biomedical sector [1] Industry Summary - The company's business scope includes advanced areas such as human gene diagnosis, stem cell technology, and cell technology, which are critical in the rapidly evolving biomedical industry [1]